ADC Therapeutics SA (ADCT)
NYSE: ADCT · Real-Time Price · USD
1.990
+0.050 (2.58%)
Nov 22, 2024, 4:00 PM EST - Market closed
ADC Therapeutics Market Cap
ADC Therapeutics has a market cap or net worth of $192.41 million as of November 22, 2024. Its market cap has increased by 176.00% in one year.
Market Cap
192.41M
Enterprise Value
372.54M
1-Year Change
176.00%
Ranking
Category
Stock Price
$1.99
Market Cap Chart
Since May 15, 2020, ADC Therapeutics's market cap has decreased from $2.04B to $192.41M, a decrease of -90.58%. That is a compound annual growth rate of -40.72%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 19, 2024 | 199.18M | 48.54% |
| Dec 29, 2023 | 134.10M | -56.31% |
| Dec 30, 2022 | 306.95M | -80.20% |
| Dec 31, 2021 | 1.55B | -37.60% |
| Dec 31, 2020 | 2.48B | 21.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Personalis | 191.63M |
| Zura Bio | 191.31M |
| Sight Sciences | 190.84M |
| Accuray | 190.07M |
| Compass Therapeutics | 189.87M |
| Profound Medical | 186.42M |
| Nektar Therapeutics | 186.30M |
| BrainsWay | 183.22M |